Sinorda pharmaceutical participated in the 16th BIO Asia international conference in Tokyo, Japan on March 5-6, 2019. At the conference, Chairman Dr. Hu Pingsheng has introduced the R&D lines of this company and the the progress of innovative drug X842 in China-Sweden phase I clinical trial to attended guest. The BIO Asia international conference brings together colleagues from the global biotechnology and pharmaceutical industries to explore cooperation and investment opportunities in the current asia-pacific business and policy environment.